slotkoers
Korea S.E.
00:00:00 21-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
1.617
KRW
|
0,00%
|
|
-2,77%
|
-18,37%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
123.574
|
107.013
|
154.280
|
116.484
|
72.957
|
61.371
|
Bedrijfswaarde
1 |
125.725
|
110.220
|
155.479
|
122.774
|
83.186
|
74.512
|
K/w-verhouding
|
193
x
|
-118
x
|
-117
x
|
-14,5
x
|
130
x
|
-5,84
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
1,96
x
|
1,58
x
|
2,36
x
|
2,02
x
|
1,06
x
|
0,97
x
|
Bedrijfswaarde/omzet
|
1,99
x
|
1,63
x
|
2,38
x
|
2,13
x
|
1,21
x
|
1,18
x
|
Bedrijfswaarde/EBITDA
|
36,7
x
|
45,9
x
|
130
x
|
-29,9
x
|
43,6
x
|
-11,6
x
|
Bedrijfswaarde/FCF
|
-265
x
|
53
x
|
-95,8
x
|
-39,7
x
|
-24,9
x
|
-87,6
x
|
FCF Yield
|
-0,38%
|
1,89%
|
-1,04%
|
-2,52%
|
-4,01%
|
-1,14%
|
Price to Book
|
2,29
x
|
2,02
x
|
2,65
x
|
2,33
x
|
1,38
x
|
1,5
x
|
Aantal aandelen (in duizenden)
|
28.310
|
28.310
|
30.980
|
30.980
|
30.980
|
30.980
|
Referentieprijs
2 |
4.365
|
3.780
|
4.980
|
3.760
|
2.355
|
1.981
|
Datum van publicatie
|
14-03-19
|
16-03-20
|
19-03-21
|
18-03-22
|
17-03-23
|
15-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
63.090
|
67.537
|
65.360
|
57.561
|
68.880
|
62.974
|
EBITDA
1 |
3.430
|
2.403
|
1.194
|
-4.109
|
1.906
|
-6.405
|
Bedrijfsresultaat (EBIT)
1 |
1.325
|
-408,4
|
-1.856
|
-7.003
|
-482,2
|
-8.792
|
Operationele Marge
|
2,1%
|
-0,6%
|
-2,84%
|
-12,17%
|
-0,7%
|
-13,96%
|
Resultaat voor belastingen (EBT)
1 |
372,1
|
-1.156
|
-1.767
|
-7.146
|
-424,4
|
-10.934
|
Nettowinst (verlies)
1 |
641,1
|
-905,3
|
-1.319
|
-8.044
|
560,7
|
-10.514
|
Nettomarge
|
1,02%
|
-1,34%
|
-2,02%
|
-13,97%
|
0,81%
|
-16,7%
|
WPA
2 |
22,65
|
-32,00
|
-42,57
|
-259,6
|
18,10
|
-339,4
|
Free Cash Flow
1 |
-474,5
|
2.081
|
-1.623
|
-3.096
|
-3.337
|
-850,3
|
FCF-marge
|
-0,75%
|
3,08%
|
-2,48%
|
-5,38%
|
-4,84%
|
-1,35%
|
Kasstroomconversie (ebitda)
|
-
|
86,61%
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
14-03-19
|
16-03-20
|
19-03-21
|
18-03-22
|
17-03-23
|
15-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
2.151
|
3.207
|
1.199
|
6.289
|
10.229
|
13.141
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
0,6271
x
|
1,335
x
|
1,004
x
|
-1,531
x
|
5,367
x
|
-2,052
x
|
Free Cash Flow
1 |
-474
|
2.081
|
-1.623
|
-3.096
|
-3.337
|
-850
|
ROE (netto-inkomsten/eigen vermogen)
|
1,16%
|
-2,14%
|
-2,96%
|
-15,3%
|
1,03%
|
-24,7%
|
ROA (netto-inkomsten/totale activa)
|
0,99%
|
-0,3%
|
-1,37%
|
-5,37%
|
-0,36%
|
-6,87%
|
Totale activa
1 |
64.860
|
302.982
|
96.145
|
149.685
|
-154.589
|
152.947
|
Nettoactief per aandeel
2 |
1.906
|
1.874
|
1.882
|
1.611
|
1.706
|
1.323
|
Cashflow per aandeel
2 |
358,0
|
355,0
|
134,0
|
186,0
|
146,0
|
66,10
|
Capex
1 |
1.972
|
1.389
|
3.598
|
3.544
|
2.782
|
831
|
Capex/omzet
|
3,13%
|
2,06%
|
5,51%
|
6,16%
|
4,04%
|
1,32%
|
Datum van publicatie
|
14-03-19
|
16-03-20
|
19-03-21
|
18-03-22
|
17-03-23
|
15-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -18,37% | 36,83 mln. | | +22,35% | 44,12 mld. | | +22,22% | 22,61 mld. | | +17,81% | 15,11 mld. | | +15,73% | 13,61 mld. | | +57,91% | 13,34 mld. | | -8,98% | 6,94 mld. | | -0,05% | 6,79 mld. | | +15,65% | 5,75 mld. | | -8,87% | 5,73 mld. |
Generieke geneesmiddelen
|